Reshma Tendulkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Reshma Tendulkar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Mugdha Tendulkar
K. J. Somaiya Medical College & Research Centre, Mumbai, India
6 shared publications Mugdha Tendulkar
K. J. Somaiya Medical College and Research Centre
2 shared publications- Alpa Yadav
Department of Chemistry, Ranchi University, Ranchi 834001, India
1 shared publication - Bhairavee Chimane
VES college of pharmacy, Chembur
1 shared publication - Gholamreza Abdi
Department of Biotechnology, Persian Gulf Research Institute, Persian Gulf University, Bushehr, Iran
1 shared publication - Mukul Jain
Research and Development Cell, Parul University, Vadodara, India
1 shared publication
Latest Publications
- 23 February 2026
- Published by Springer Nature
- p. 45-55
Advanced Methods for Rapid Screening: Evolution of Artificial Intelligence
- 23 February 2026
- Published by Springer Nature
- p. 45-55
Advanced Methods for Rapid Screening: Evolution of Artificial Intelligence
- 9 January 2026
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 84 (2) , 1647-1663
Unveiling the Influence of Polyphenols on Mitogen-activated Protein Kinases in Cancer
- 9 January 2026
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 84 (2) , 1647-1663
Unveiling the Influence of Polyphenols on Mitogen-activated Protein Kinases in Cancer
- 1 January 2026
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 357, 112134
Enlarged cavum septum pellucidum & increased incidence of schizophrenia: Narrative review for neurodevelopmental correlate
- 1 January 2026
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 357, 112134
Enlarged cavum septum pellucidum & increased incidence of schizophrenia: Narrative review for neurodevelopmental correlate
- 20 December 2025
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 115, 104795
Amalgamating artificial intelligence & neuropsychiatry: Multimodal approach for precision diagnosis
- 20 December 2025
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 115, 104795
Amalgamating artificial intelligence & neuropsychiatry: Multimodal approach for precision diagnosis
- 20 November 2024
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 103, 104312
Childhood trauma & associated increased incidence of Alzheimer’s disease and its long-term structural effects on the brain
- 20 November 2024
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 103, 104312
Childhood trauma & associated increased incidence of Alzheimer’s disease and its long-term structural effects on the brain
- 1 January 2024
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 24 (1) , 26-39
Current Update of Research on Exosomes in Cancer
Exosomes are vesicles secreted by the plasma membrane of the cells delimited by a lipid bilayer membrane into the extracellular space of the cell. Their release is associated with the disposal mechanism to remove unwanted materials from the cells. Exosomes released from primary tumour sites migrate to other parts of the body to create a metastatic environment for spreading the tumour cells. We have reviewed that exosomes interfere with the tumour progression by (i) promoting angiogenesis, (ii) initiating metastasis, (iii) regulating tumour microenvironment (TME) and inflammation, (iv) modifying energy metabolism, and (v) transferring mutations. We have found that EVs play an important role in inducing tumour drug resistance against anticancer drugs. This review discusses the potential of exosomes to generate a significant therapeutic effect along with improved diagnosis, prognosis, insights on the various research conducted and their significant findings of our interest.
- 1 January 2024
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 24 (1) , 26-39
Current Update of Research on Exosomes in Cancer
Exosomes are vesicles secreted by the plasma membrane of the cells delimited by a lipid bilayer membrane into the extracellular space of the cell. Their release is associated with the disposal mechanism to remove unwanted materials from the cells. Exosomes released from primary tumour sites migrate to other parts of the body to create a metastatic environment for spreading the tumour cells. We have reviewed that exosomes interfere with the tumour progression by (i) promoting angiogenesis, (ii) initiating metastasis, (iii) regulating tumour microenvironment (TME) and inflammation, (iv) modifying energy metabolism, and (v) transferring mutations. We have found that EVs play an important role in inducing tumour drug resistance against anticancer drugs. This review discusses the potential of exosomes to generate a significant therapeutic effect along with improved diagnosis, prognosis, insights on the various research conducted and their significant findings of our interest.
- Open Access
Unveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer’s Disease
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Early and accurate diagnosis of AD is crucial for implementing timely interventions and developing effective therapeutic strategies. Proteome-based biomarkers have emerged as promising tools for AD diagnosis and prognosis due to their ability to reflect disease-specific molecular alterations. There is of great significance for biomarkers in AD diagnosis and management. It emphasizes the limitations of existing diagnostic approaches and the need for reliable and accessible biomarkers. Proteomics, a field that comprehensively analyzes the entire protein complement of cells, tissues, or bio fluids, is presented as a powerful tool for identifying AD biomarkers. There is a diverse range of proteomic approaches employed in AD research, including mass spectrometry, two-dimensional gel electrophoresis, and protein microarrays. The challenges associated with identifying reliable biomarkers, such as sample heterogeneity and the dynamic nature of the disease. There are well-known proteins implicated in AD pathogenesis, such as amyloid-beta peptides, tau protein, Apo lipoprotein E, and clusterin, as well as inflammatory markers and complement proteins. Validation and clinical utility of proteome-based biomarkers are addressing the challenges involved in validation studies and the diagnostic accuracy of these biomarkers. There is great potential in monitoring disease progression and response to treatment, thereby aiding in personalized medicine approaches for AD patients. There is a great role for bioinformatics and data analysis in proteomics for AD biomarker research and the importance of data preprocessing, statistical analysis, pathway analysis, and integration of multi-omics data for a comprehensive understanding of AD pathophysiology. In conclusion, proteome-based biomarkers hold great promise in the field of AD research. They provide valuable insights into disease mechanisms, aid in early diagnosis, and facilitate personalized treatment strategies. However, further research and validation studies are necessary to harness the full potential of proteome-based biomarkers in clinical practice.
Open AccessUnveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer’s Disease
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Early and accurate diagnosis of AD is crucial for implementing timely interventions and developing effective therapeutic strategies. Proteome-based biomarkers have emerged as promising tools for AD diagnosis and prognosis due to their ability to reflect disease-specific molecular alterations. There is of great significance for biomarkers in AD diagnosis and management. It emphasizes the limitations of existing diagnostic approaches and the need for reliable and accessible biomarkers. Proteomics, a field that comprehensively analyzes the entire protein complement of cells, tissues, or bio fluids, is presented as a powerful tool for identifying AD biomarkers. There is a diverse range of proteomic approaches employed in AD research, including mass spectrometry, two-dimensional gel electrophoresis, and protein microarrays. The challenges associated with identifying reliable biomarkers, such as sample heterogeneity and the dynamic nature of the disease. There are well-known proteins implicated in AD pathogenesis, such as amyloid-beta peptides, tau protein, Apo lipoprotein E, and clusterin, as well as inflammatory markers and complement proteins. Validation and clinical utility of proteome-based biomarkers are addressing the challenges involved in validation studies and the diagnostic accuracy of these biomarkers. There is great potential in monitoring disease progression and response to treatment, thereby aiding in personalized medicine approaches for AD patients. There is a great role for bioinformatics and data analysis in proteomics for AD biomarker research and the importance of data preprocessing, statistical analysis, pathway analysis, and integration of multi-omics data for a comprehensive understanding of AD pathophysiology. In conclusion, proteome-based biomarkers hold great promise in the field of AD research. They provide valuable insights into disease mechanisms, aid in early diagnosis, and facilitate personalized treatment strategies. However, further research and validation studies are necessary to harness the full potential of proteome-based biomarkers in clinical practice.
- 28 April 2023
- Published by Indian Drug Manufacturers' Association (IDMA) in INDIAN DRUGS
- Vol. 60 (04) , 41-51
OPTIMIZATION AND GREEN SYNTHESIS OF SILVER AND GOLD NANO-PARTICLES DERIVED FROM COLOCASIA ESCULENTA ROOT EXTRACT AND THEIR POTENTIAL PHARMACOLOGICAL APPLICATIONS
The broad array of potential applications of silver and gold nano-particles in diverse fields is well-known. The utilization of lethal reagents is included in the contemporary procedures of synthesizing nanoparticles. In present times, there is necessity to augment novel mechanisms that lead to the synthesis of gold and silver nano-particles with the help of environmentally safe reagents. The reliable green synthesis of silver and gold nano-particles with the help of Colocasia esculenta root extract popularly called as Arvi, has been investigated here. The experimental procedure employed here to scrutinize and observe the synthesis of silver and gold nano-particles based on quantity is UV-Vis absorption spectroscopy. Surface Plasmon Resonance (SPR) was exhibited by UV/Vis spectrum for silver and gold nano-particles at 420 and 540 nanometers, respectively. The mean diameter of gold and silver nanoparticles synthesized in the solution was found to be 85 nm and 105 nm, respectively. The particles that were synthesized had a spherical shape.
- 28 April 2023
- Published by Indian Drug Manufacturers' Association (IDMA) in INDIAN DRUGS
- Vol. 60 (04) , 41-51
OPTIMIZATION AND GREEN SYNTHESIS OF SILVER AND GOLD NANO-PARTICLES DERIVED FROM COLOCASIA ESCULENTA ROOT EXTRACT AND THEIR POTENTIAL PHARMACOLOGICAL APPLICATIONS
The broad array of potential applications of silver and gold nano-particles in diverse fields is well-known. The utilization of lethal reagents is included in the contemporary procedures of synthesizing nanoparticles. In present times, there is necessity to augment novel mechanisms that lead to the synthesis of gold and silver nano-particles with the help of environmentally safe reagents. The reliable green synthesis of silver and gold nano-particles with the help of Colocasia esculenta root extract popularly called as Arvi, has been investigated here. The experimental procedure employed here to scrutinize and observe the synthesis of silver and gold nano-particles based on quantity is UV-Vis absorption spectroscopy. Surface Plasmon Resonance (SPR) was exhibited by UV/Vis spectrum for silver and gold nano-particles at 420 and 540 nanometers, respectively. The mean diameter of gold and silver nanoparticles synthesized in the solution was found to be 85 nm and 105 nm, respectively. The particles that were synthesized had a spherical shape.
- Open Access
- 17 January 2023
- Published by Association for the International Development of Academic and Scientific Collaboration in AIDASCO Reviews
- Vol. 1 (1) , 14-17
Is Oncolytic Virotherapy a permanent cure for malignant gliomas?
Of all malignant glioma forms, glioblastoma is the most frequently present form. The treatment of this highly aggressive tumor form by applying conventional therapies is of low success, leading to a low survival rate. As representatives of immunotherapeutic agents, oncolytic viruses contribute to the revolution in cancer therapy. Although promising, the efficiency of oncolytic viruses for treating glioblastoma is also limited. This is a reason why further optimization of oncolytic virotherapy is necessary. In this work, we review some of glioblastoma's specificities and provide information about the current status of oncolytic virotherapy.
- 17 January 2023
- Published by Association for the International Development of Academic and Scientific Collaboration in AIDASCO Reviews
- Vol. 1 (1) , 14-17
Open AccessIs Oncolytic Virotherapy a permanent cure for malignant gliomas?
Of all malignant glioma forms, glioblastoma is the most frequently present form. The treatment of this highly aggressive tumor form by applying conventional therapies is of low success, leading to a low survival rate. As representatives of immunotherapeutic agents, oncolytic viruses contribute to the revolution in cancer therapy. Although promising, the efficiency of oncolytic viruses for treating glioblastoma is also limited. This is a reason why further optimization of oncolytic virotherapy is necessary. In this work, we review some of glioblastoma's specificities and provide information about the current status of oncolytic virotherapy.
- Open Access
- 17 January 2023
- Published by Association for the International Development of Academic and Scientific Collaboration in AIDASCO Reviews
- Vol. 1 (1) , 31-37
Integrating modern medicine and traditional herbs in the treatment of Endometriosis
Endometriosis is the proliferation of various tissues that resemble the uterine lining; these tissues develop inside lower abdominal reproductive organs, such as the ovaries, fallopian tubes, tissues that support the uterus, and other uterine surface regions. The lungs, brain, and skin are examples of non-pelvic tissues where spreadability was seen. However, endometrial-problem may also result in Ovarian Cancer and breast cancer if proper treatment of endometriosis in women is ignored. In conventional pharmaceutical therapies, nonsteroidal anti-inflammatory drugs, as well as androgens, aromatase inhibitors, selective progesterone receptor modulators, oral contraceptives, and gonadotropin-releasing hormone agonists, are used.
- 17 January 2023
- Published by Association for the International Development of Academic and Scientific Collaboration in AIDASCO Reviews
- Vol. 1 (1) , 31-37
Open AccessIntegrating modern medicine and traditional herbs in the treatment of Endometriosis
Endometriosis is the proliferation of various tissues that resemble the uterine lining; these tissues develop inside lower abdominal reproductive organs, such as the ovaries, fallopian tubes, tissues that support the uterus, and other uterine surface regions. The lungs, brain, and skin are examples of non-pelvic tissues where spreadability was seen. However, endometrial-problem may also result in Ovarian Cancer and breast cancer if proper treatment of endometriosis in women is ignored. In conventional pharmaceutical therapies, nonsteroidal anti-inflammatory drugs, as well as androgens, aromatase inhibitors, selective progesterone receptor modulators, oral contraceptives, and gonadotropin-releasing hormone agonists, are used.